Apellis Pharmaceuticals, Inc.

NASDAQ:APLS

27.98 (USD) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 199.685172.325146.37799.18294.96944.84622.66322.05616.32214.38160.295.650.62302500.64600-0.1420000.0120000.012000000000000000
Cost of Revenue 23.54920.65319.91222.418.3797.8092.9251.3810.0821.2475.0510.14950124.59154.00693.207115.50898.786220.96969.94863.47648.651035.80533.48521.438011.58900000000000000
Gross Profit 176.136151.672126.46576.77286.5937.03719.73820.67516.2413.13455.2395.501-49.377-124.591195.994-92.561-115.508-98.786-221.111-69.948-63.476-48.6510.012-35.805-33.485-21.4380.012-11.58900000000000000
Gross Profit Ratio 0.8820.880.8640.7740.9120.8260.8710.9370.9950.9130.9160.974-79.25700.784-143.283001,555.47800010001000000000000000
Reseach & Development Expenses 77.94784.70169.28279.42195.658110.02799.42395.207101.66190.945103.18187.733145.94384.01250.33793.20787.09469.28278.47151.31950.69840.4830.80629.53927.53817.40313.1339.51810.4227.2315.5926.2345.5765.5763.9283.7453.0283.0281.8891.9972.2472.247
General & Administrative Expenses 00141.701145.648111.373102.09384.36878.40663.20351.18741.46245.76348.96740.57944.49236.99128.41429.50427.46918.62912.7788.1716.3916.2655.9484.0354.862.0711.711.8211.08711.1081.1083.0431.4130.9510.9511.0260.670.6060.606
Selling & Marketing Expenses 000000000000000000000000000000000000000000
SG&A 127.632129.061141.701145.648111.373102.09384.36878.40663.20351.18741.46245.76348.96740.57944.49236.99128.41429.50427.46918.62912.7788.1716.3916.2655.9484.0354.862.0711.711.8211.08711.1081.1083.0431.4130.9510.9511.0260.670.6060.606
Other Expenses 0.024-0.4990.219-0.603-0.063-0.277-0.2460.0990.149-0.289-0.004-0.117-0.0611.544-0.505-0.0160.0050.014-0.089-0.0610.228-0.253-0.024-0.022-0.033-0.031-0.0120.0160-0.0080.0590.02400-0.0330.015000.0320.00600
Operating Expenses 205.579213.762210.983225.069207.031212.12183.791173.613164.864142.132144.643133.496194.91124.59194.829130.198115.50898.786105.9469.94863.47648.65137.19735.80533.48521.43817.99311.58912.1329.0526.6797.2346.6476.6476.9655.163.9693.9692.9172.6692.8432.843
Operating Income -29.443-62.09-84.518-148.297-120.441-175.083-164.053-152.938-148.624-128.998-89.404-127.995-194.287-124.591130.121-129.552-115.508-98.786-105.94-69.948-63.476-48.651-37.197-35.805-33.485-21.438-17.993-11.589-12.132-9.052-6.679-7.234-6.685-6.685-6.965-31.646-3.981-3.981-2.917-2.669-2.855-2.855
Operating Income Ratio -0.147-0.36-0.577-1.495-1.268-3.904-7.239-6.934-9.106-8.97-1.483-22.654-311.85700.52-200.54500745.271000-3,222.716000-1,558.899000000000000000
Total Other Income Expenses Net -8.1-4.163-2.6358.293-0.063-2.413-3.409-37.885-6.867-8.729-55.196-65.438-21.241-55.027-40.5952.6812.775-68.392-4.825-0.617-8.876-2.1970.488-0.448-0.033-0.031-0.1660.0160-0.0080.0590.0240.0380.038-0.033-26.4710.0120.0120.0320.0060.0120.012
Income Before Tax -37.543-66.253-87.153-140.004-121.843-177.496-167.462-190.823-155.491-137.727-147.581-195.571-219.191-183.65980.11-135.7-118.617-168.822-113.217-69.825-71.09-50.574-36.459-35.972-33.334-21.736-18.256-11.573-12.126-9.051-6.62-7.211-6.647-6.647-6.947-31.632-3.969-3.969-2.884-2.662-2.843-2.843
Income Before Tax Ratio -0.188-0.384-0.595-1.412-1.283-3.958-7.389-8.652-9.526-9.577-2.448-34.614-351.83100.32-210.06200796.464000-3,158.852000-1,581.693000000000000000
Income Tax Expense 0.1140.171.4230.2330.1940.282-1.4710.4460.4861.2080.3522.1653.7065.7190.0029.4836.9143.9333.9810.540.3880.342.383-0.281-33.6690.267-17.896-11.589-12.138-9.063-6.679-7.2340.0380.0381.269-0.4420.4130.413-0.195-0.1920.0280.028
Net Income -37.657-66.423-88.576-140.237-122.037-177.778-165.991-191.269-155.977-138.935-147.933-195.571-219.191-183.65978.265-135.7-118.617-168.822-113.217-69.825-71.09-50.574-36.459-35.972-33.334-21.736-18.256-11.573-12.126-9.051-6.62-7.211-6.647-6.647-8.216-31.189-3.555-3.555-2.689-2.47-2.815-2.815
Net Income Ratio -0.189-0.385-0.605-1.414-1.285-3.964-7.324-8.672-9.556-9.661-2.454-34.614-351.83100.313-210.06200796.464000-3,158.852000-1,581.693000000000000000
EPS -0.3-0.54-0.73-1.17-1.02-1.56-1.5-1.75-1.46-1.42-1.73-2.28-2.72-2.320.99-1.79-1.57-2.29-1.54-1.1-1.12-0.87-0.65-0.64-0.61-0.43-0.36-0.3-0.67-0.5-0.37-0.4-0.79-0.79-0.45-1.72-0.78-0.78-0.15-0.14-0.61-0.61
EPS Diluted -0.3-0.54-0.73-1.17-1.02-1.56-1.5-1.75-1.46-1.42-1.73-2.28-2.72-2.320.99-1.79-1.57-2.29-1.54-1.1-1.12-0.87-0.63-0.64-0.61-0.43-0.36-0.3-0.67-0.5-0.37-0.4-0.79-0.79-0.45-1.72-0.78-0.78-0.15-0.14-0.61-0.61
EBITDA -28.994-61.646-84.028-148.297-114.502-169.568-159.296-149.673-146.701-128.829-88.995-127.694-193.796-122.519129.868-128.583-114.356-96.355-104.551-68.524-61.704-47.924-34.773-35.378-33.485-21.23-17.993-11.589-12.132-9.052-6.679-7.2340.0380.038-6.965-5.158-3.979-3.979-2.915-2.667-2.853-2.853
EBITDA Ratio -0.145-0.358-0.574-1.495-1.206-3.781-7.029-6.786-8.988-8.958-1.476-22.601-311.06900.519-199.04500735.499000-3,012.716000-1,558.899000000000000000